Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its oncology product candidate is etigilimab, for patients with solid tumors. Some of the other products in the pipeline are setrusumab, alvelestat,...
This is not a financial advice! Vol . is slowly increasing SL under 1.10 or if u want more risk under 0.9 TP 1.8 to 2.0 Most info on the chart. Trade carefully!
^ Key Words: I'm kicking us off with my pick, which is Mereo Biopharma. Now the stock was actually popping today on an article in "The Times" that says AstraZeneca is putting in a bid for the company. As you can see there, the stock up 73% there. And AstraZeneca also getting a slight boost as well. Now Mereo is a London-based US-listed company that specializes in...
Long with a small position established. Financials are looking good to 2025 with enough cash to meet demands of trials. Leading up to the osteogenesis imperfecta results was large cluster insider buying along with sentiment from CEO at interviews leading up to results being extremely positive. Volume pick up and bullish engulfing on the weekly looking to move off...
MREO after forming an inverted head and shoulders on the weekly chart, the price just broke the neckline and triggered a long trade. Approximate target between 7 and 8. Trade safe.
Long here. Awaiting good news from R&D day next week. Analysts putting targets at $10. Altium Capital with the 13F, showing 1,250,000 shares owned.
MERO: A very, very interesting stock that jumped on the scanner (as a potential short squeeze stock) Its data: ID: (You can see a lots of insider and institutional deals) finviz.com Significant events in the near future (positive / negative catalysts): finance.yahoo.com Analyst Price Target on MREO : www.tipranks.com If we break the 4.79 we can see a violent...
i can see 3 different patterns to push her higher 1) this flag i just drew out looks great looking for a break of $4.15 2) fill up a cup and handle, look at PD's chart, makes a U shape 3) inverse head and shoulders all of these make sense for it to go to abt $6 after that and a cool off next leg would be to $10 bonus 4) the moving averages r in great spots
MREO is a good company off the bat to fill the cup is a %100 move and after the cup $10 is very reasonable after the handle could have catalysts in the mean time $10 conservative pt this is a swing trade MACD looks great as well
$MERO has held up really well over the draw down of the last 4-5 days. I would keep this on your radar as there is a strong follow-thru on this stock.
Bullish Flag Pros: Descending Volume during formation PPS above 50MA and 200MA RS above 0, and ascending ATR Ascending R/R ratio above 4 200MA ascending Cons: 250RSI below 50 Target: PT = 5.89$ 1000 Followers! Thank you all! Thank you to those who donate Coins! Stay Humble, have fun, make money!
Caught this one on Friday. Looks like a decent setup to pull back and add for a final wave 5 on the hourly. If the pullback is accomplished, then equal legs target will be around 5 dollar range. If 3.88 fails, then this setup is invalidated.
looks like this downtrend on the daily has shifted into an uptrend. will be watching for entries
a clinical-stage company focused on developing & commercialising oncology & rare diseases treatments.
MREO: Mereo BioPharma Group plc 2020-10-19 07:00:10 Mereo BioPharma Announces FDA Clearance to Proceed into a Phase 1b/2 study for Etigilimab (Anti-TIGIT)
Upcoming data release sometime expected now through summer. Will be holding this for 2 months max.
Mereo BioPharma Group Plc engages in the acquisition, development, and commercialization of therapeutics that aim to improve outcomes for patients with rare and specialty diseases. It focuses on the treatment of patients with osteogenesis imperfecta, alpha-1 antitrypsin deficiency, hypogonadotropic hypogonadism in obese men, and acute exacerbations of chronic...